肥厚型心肌病:运动处方与竞技体育参与范式的转变
本文综述了肥厚型心肌病(HCM)患者参与剧烈运动与竞技体育的最新证据。观察性研究与随机试验显示,在低危患者(无高ESC HCM猝死风险评分、运动诱发晕厥、严重左心室流出道梗阻及室性心律失常)中,个体化运动可改善功能容量、生活质量及心血管与心理健康,且未出现安全性信号。文章主张以个体化、目标导向的运动处方和多学科共同决策替代系统性排除。
要点
- 低危HCM患者参与竞技体育的安全性正获国际广泛接受,但各地法规与临床做法存在差异。
- 低危界定依据为无高ESC HCM猝死风险评分、运动诱发晕厥、严重左心室流出道梗阻和室性心律失常。
- 非低危患者证据有限,可在风险缓解(如解除梗阻、按指征植入ICD)后个体化考虑竞技体育。
核心结论
- 新兴证据挑战了HCM患者应系统排除于剧烈运动和竞技体育之外的传统范式。
- 低危HCM个体参与竞技体育未观察到安全性信号,该概念正被国际广泛接受。
- 当代HCM管理应基于个体化、目标导向的运动处方与多学科共同决策。
研究设计与样本
- 本文为综述,批判性评价HCM剧烈运动与竞技体育的新兴证据并探讨其对临床实践和国际指南的影响。
- 证据来源包括观察性研究与随机试验,研究对象为HCM人群。
主要发现
- 定制运动使HCM人群功能容量、生活质量及整体心血管与心理健康改善,且无安全性信号。
- 低危个体包括参加竞技体育者,同样未见安全性信号。
- 非低危个体证据较为有限。
关键数值与推荐
- 低危定义为缺乏已确立的不良特征:高欧洲心脏病学会(ESC)HCM猝死风险评分、运动诱发晕厥、严重左心室流出道梗阻和室性心律失常。
- 非低危个体经适当风险缓解策略(包括治疗梗阻及按指征植入ICD)后仍可个体化考虑竞技体育。
临床怎么用
- 对HCM患者采用个体化、目标导向的运动处方,而非一律限制运动。
- 以多学科咨询和共同决策支持运动建议,兼顾安全、患者价值观、目标与生活质量。
- 低危者可考虑竞技体育;非低危者先实施风险缓解策略再个体化评估。
局限性
- 非低危HCM个体参与剧烈运动与竞技体育的证据较为有限。
- 各国在法规和临床处理方式上存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Historically, individuals with hypertrophic cardiomyopathy (HCM) have been systematically excluded from vigorous exercise and competitive sports due to concerns about increased sudden cardiac death (SCD) risk. However, emerging evidence has challenged this paradigm. Observational studies and randomized trials demonstrate improvements in functional capacity, quality of life, and overall cardiovascular and psychological health with tailored exercise in HCM populations -including competitive sports in low-risk individuals-in the absence of safety signals. Low-risk individuals are defined by the lack of well-established adverse features such as a high European Society of Cardiology HCM SCD risk score, exercise-induced syncope, severe left ventricular outflow tract obstruction and ventricular arrhythmias. The concept that this low-risk subset can safely engage in competitive sports is becoming widely accepted internationally, although local differences exist in terms of regulations and clinical approaches. For individuals who do not meet low-risk criteria, evidence is more limited. Nevertheless, participation in competitive sports may still be considered on an individual basis, after appropriate risk mitigation strategies (including treatment of obstruction and ICD implantation when indicated). A contemporary approach to HCM should be based on individualized, goal-oriented exercise prescription, supported by multidisciplinary counselling and shared decision-making, recognizing the importance of aligning medical recommendations with individual safety, values, goals, and quality of life. In this review, we critically appraise the emerging evidence surrounding vigorous exercise and competitive sports in HCM and explore how novel data are reshaping clinical practice and international guidelines, setting the stage for a paradigm in the field.
引用
- Zampieri M, Saberi S, D'Ascenzi F, et al. Hypertrophic cardiomyopathy: changing the paradigm of exercise prescription and competitive sport participation. Eur Heart J. 2026. PMID: 41065586. doi:10.1093/eurheartj/ehaf770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。